84 related articles for article (PubMed ID: 1493810)
41. Transcription of genes encoding granulocyte-macrophage colony-stimulating factor, interleukin 3, and interleukin 6 receptors and lack of proliferative response to exogenous cytokines in nonhematopoietic human malignant cell lines.
Guillaume T; Sekhavat M; Rubinstein DB; Hamdan O; Symann ML
Cancer Res; 1993 Jul; 53(13):3139-44. PubMed ID: 8319222
[TBL] [Abstract][Full Text] [Related]
42. Interleukin-6 and 12-O-tetradecanoyl phorbol-13-acetate act synergistically in inducing cell-cell separation and migration of human breast carcinoma cells.
Tamm I; Cardinale I; Sehgal PB
Cytokine; 1991 May; 3(3):212-23. PubMed ID: 1653054
[TBL] [Abstract][Full Text] [Related]
43. Heterogeneity of the motility responses in malignant tumor cells: a biological basis for the diversity and homing of metastatic cells.
Kohn EC; Francis EA; Liotta LA; Schiffmann E
Int J Cancer; 1990 Aug; 46(2):287-92. PubMed ID: 2116998
[TBL] [Abstract][Full Text] [Related]
44. Effects of human fibroblasts on invasiveness of oral cancer cells in vitro: isolation of a chemotactic factor from human fibroblasts.
Sugiura T; Shirasuna K; Hayashido Y; Sakai T; Matsuya T
Int J Cancer; 1996 Dec; 68(6):774-81. PubMed ID: 8980183
[TBL] [Abstract][Full Text] [Related]
45. The influence of inflammatory cytokines on estrogen production and cell proliferation in human breast cancer cells.
Honma S; Shimodaira K; Shimizu Y; Tsuchiya N; Saito H; Yanaihara T; Okai T
Endocr J; 2002 Jun; 49(3):371-7. PubMed ID: 12201223
[TBL] [Abstract][Full Text] [Related]
46. Characterization of interleukin-1 alpha-induced melanoma cell motility: inhibition by type I and type II receptor-blocking monoclonal antibodies.
Dekker SK; Vink J; Bruijn JA; Mihm MC; Vermeer BJ; Byers HR
Melanoma Res; 1997 Jun; 7(3):223-30. PubMed ID: 9195561
[TBL] [Abstract][Full Text] [Related]
47. Interleukin 6 decreases cell-cell association and increases motility of ductal breast carcinoma cells.
Tamm I; Cardinale I; Krueger J; Murphy JS; May LT; Sehgal PB
J Exp Med; 1989 Nov; 170(5):1649-69. PubMed ID: 2553849
[TBL] [Abstract][Full Text] [Related]
48. Interleukin-6 stimulates motility of vascular endothelium.
Rosen EM; Liu D; Setter E; Bhargava M; Goldberg ID
EXS; 1991; 59():194-205. PubMed ID: 1833229
[TBL] [Abstract][Full Text] [Related]
49. Interleukin-6 enhances motility of breast carcinoma cells.
Sehgal PB; Tamm I
EXS; 1991; 59():178-93. PubMed ID: 1655518
[TBL] [Abstract][Full Text] [Related]
50. Interleukin-1 induces a pertussis toxin-sensitive increase in diacylglycerol accumulation in mouse thymoma cells.
Dobson PR; Plested CP; Jones DR; Barks T; Brown BL
J Mol Endocrinol; 1989 May; 2(3):R5-7. PubMed ID: 2787652
[TBL] [Abstract][Full Text] [Related]
51. Effect of pertussis toxin and PGE2 on the functioning of the IL-2 promoter in interleukin-1 treated EL4.NOB-1 thymoma cells.
McCarthy LM; O'Neill LA
Biochem Soc Trans; 1996 Feb; 24(1):82S. PubMed ID: 8674763
[No Abstract] [Full Text] [Related]
52. Cell-adhesion-disrupting action of interleukin 6 in human ductal breast carcinoma cells.
Tamm I; Kikuchi T; Cardinale I; Krueger JG
Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3329-33. PubMed ID: 7512730
[TBL] [Abstract][Full Text] [Related]
53. Decreased adherence of interleukin 6-treated breast carcinoma cells can lead to separation from neighbors after mitosis.
Tamm I; Cardinale I; Murphy JS
Proc Natl Acad Sci U S A; 1991 May; 88(10):4414-8. PubMed ID: 1852008
[TBL] [Abstract][Full Text] [Related]
54. A 50 kDa protein present in conditioned medium of COLO-16 cells stimulates cell spreading and motility, and activates tyrosine phosphorylation of Neu/HER-2, in human SK-BR-3 mammary cancer cells.
De Corte V; De Potter C; Vandenberghe D; Van Laerebeke N; Azam M; Roels H; Mareel M; Vandekerckhove J
J Cell Sci; 1994 Mar; 107 ( Pt 3)():405-16. PubMed ID: 7911804
[TBL] [Abstract][Full Text] [Related]
55. Interleukin-6 (IL-6) production and cell growth of cultured human ameningiomas:-interactions with interleukin-1 beta (IL-1 beta) and interleukin-4 (IL-4) in vitro.
Boyle-Walsh E; Hashim IA; Speirs V; Fraser WD; White MC
Neurosci Lett; 1994 Mar; 170(1):129-32. PubMed ID: 8041488
[TBL] [Abstract][Full Text] [Related]
56. Effects of recombinant human interleukin-1 beta on accumulation of inflammatory peritoneal macrophages in mice treated with pertussis toxin.
Torre D; Speranza F; Pugliese A; Tambini R
Infect Immun; 1990 Dec; 58(12):4153-5. PubMed ID: 2254036
[TBL] [Abstract][Full Text] [Related]
57. The p185erbB2 protein is localized on cell organelles involved in cell motility.
De Potter CR; Quatacker J
Clin Exp Metastasis; 1993 Nov; 11(6):453-61. PubMed ID: 7900945
[TBL] [Abstract][Full Text] [Related]
58. Enhancement of interleukin 6 cytostatic effect on human breast carcinoma cells by soluble IL-6 receptor from urine and reversion by monoclonal antibody.
Novick D; Shulman LM; Chen L; Revel M
Cytokine; 1992 Jan; 4(1):6-11. PubMed ID: 1617157
[TBL] [Abstract][Full Text] [Related]
59. A comparison of spreading and motility behaviour of 8701-BC breast carcinoma cells on type I, I-trimer and type V collagen substrata. Evidence for a permissive effect of type I-trimer collagen on cell locomotion.
Luparello C; Sheterline P; Pucci-Minafra I; Minafra S
J Cell Sci; 1991 Sep; 100 ( Pt 1)():179-85. PubMed ID: 1665496
[TBL] [Abstract][Full Text] [Related]
60. Differential stimulation of IL-6 secretion following apical and basolateral presentation of IL-1 on epithelial cell lines.
O'Shaughnessy C; Prosser E; Keane T; O'Neill L
Biochem Soc Trans; 1996 Feb; 24(1):83S. PubMed ID: 8674764
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
